Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions reflect a general interest in the study, with many referencing the trial's focus on patient-reported outcomes and the potential influence of atogepant on migraine management. The tone combines professionalism and curiosity, evident in phrases like 'Check out the latest migraine journal club' and hashtag use, which indicates active dissemination and engagement with the research findings.
Most discussions appear supportive of the article, highlighting its importance and potential benefits, with phrases like 'check out,' 'latest journal,' and references to professional credentials indicating alignment with the study's significance.
Participants show moderate curiosity, engaging in professional contexts and mentioning specific trials and outcomes, but with limited emotional or personal connection, as reflected in neutral tones and technical references.
The discourse includes references to journal clubs, scientific discussions, and social media tags, suggesting meaningful engagement and a desire to share and analyze the findings more deeply.
The emphasis on the publication's role in advancing migraine treatment and its mention in professional and academic circles suggest a moderate to high perceived impact within the medical community.
Check out the latest migraine journal club! NVJC Ep. 36 Headache and Migraine: Effect of Atogepant for Preventive Mi... https://t.co/UOluC7FmYM via @YouTube @AMastersMD #JessicaAilani @GreenJournal @ahsheadache
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/CC2lYbogpG
RT @headacheMD: Check out the latest migraine journal club! NVJC Ep. 36 Headache and Migraine: Effect of Atogepant for Preventive Mi... htt…
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/NDP4dW0KMl #hvhebron #neuro [Text complet] @GreenJournal
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/T67SUlB0EO #ScientiaVH
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial - https://t.co/VvAmA3usNR
Explore the potential of Atogepant as a preventative treatment for migraines, based on findings from the Phase 3 ADVANCE trial, and learn how it may improve patient outcomes.
This episode discusses the impact of Atogepant on patient-reported outcomes in preventing migraines, based on the Phase 3 ADVANCE trial as published in Neurology, providing insights into its efficacy and benefits.
RT @headacheMD: Check out the latest migraine journal club! NVJC Ep. 36 Headache and Migraine: Effect of Atogepant for Preventive Mi... htt…
Check out the latest migraine journal club! NVJC Ep. 36 Headache and Migraine: Effect of Atogepant for Preventive Mi... https://t.co/UOluC7FmYM via @YouTube @AMastersMD #JessicaAilani @GreenJournal @ahsheadache
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/T67SUlB0EO #ScientiaVH
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial - https://t.co/VvAmA3usNR
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/CC2lYbogpG
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/izLzfhX3Wy #neurology #doctors #medtwitter #medical #medicinenews #healthcare
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial https://t.co/NDP4dW0KMl #hvhebron #neuro [Text complet] @GreenJournal